US Patent Issued to Enveric Biosciences Canada on June 24 for "N-heterocycle substituted tryptamine derivatives and methods of using" (Canadian Inventors)

ALEXANDRIA, Va., June 25 -- United States Patent no. 12,338,231, issued on June 24, was assigned to Enveric Biosciences Canada Inc. (Calgary, Canada).

"N-heterocycle substituted tryptamine derivatives and methods of using" was invented by David James Press (Calgary, Canada), Glynnis Elizabeth Jensen (Calgary, Canada), Kaveh Matinkhoo (Calgary, Canada), Jessica Bik-Jing Lee (Calgary, Canada), Jillian M. Hagel (Calgary, Canada) and Peter J. Facchini (Calgary, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are novel N-heterocycle-substituted tryptamine derivative compounds and pharmaceutical and recreational drug formulations containing the same. The pharmaceutical formulations may be used to t...